Clinical Trial Update: Mozart Relapse Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Mozart Relapse Study in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED